2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies

2-Oxoindolin-Thiazoline Hybrids as Scaffold-Based Therapeutics for T2DM-Associated Cognitive Impairment: Design, Synthesis, in vitro and in silico studies

Research Authors
Wesam S Qayed, Mostafa A. Hassan, Halil Şenol, Parham Taslimi, Tarek Aboul-Fadl
Research Date
Research Department
Department of Medicinal Chemistry
Research Journal
RSC Medicinal Chemistry
Research Member
Tarek Aboul-Fadl Mohammad Hassan
Wesam Saber Abdel-Aal Qayed
Mostafa Ahmed Hassan Mohamed
Research Publisher
Royal Society of Chemistry
Research Rank
Q1
Research Vol
16
Research Year
2025